|
|
|
|
3 Departments of Pharmacology, Toxicology, and Therapeutics; 4 Dietetics and Nutrition; 5 Pediatrics; and 6 The Smith Mental Retardation Research Center, University of Kansas Medical Center, Kansas City, KS 66160
* To whom correspondence should be addressed. E-mail: blevant{at}kumc.edu.
| ABSTRACT |
|---|
|
|
|---|
-linolenic acid (ALA), containing ALA and pre-formed DHA (ALA+DHA), or lacking ALA (low-ALA). Virgin females, fed the diets for commensurate durations served as a control for reproduction. Whole-brain total phospholipid composition was determined at weaning by TLC/GC. A single reproductive cycle on the low-ALA diet decreased brain DHA content by 18% compared to ALA primiparas (P < 0.05), accompanied by incorporation of docosapentaenoic acid ((n-6) DPA, 22:5(n-6)) to 280% of ALA primiparas (P < 0.05). DHA was not further decreased after subsequent cycles; however, there was an additional increase in (n-6) DPA after the second cycle (P < 0.05). Brain DHA of virgin females fed the low-ALA diet for 27 wk decreased 15% (P < 0.05), but was accompanied by a more modest increase in (n-6) DPA than in parous low-ALA dams (P < 0.05). Virgin females and parous dams fed the diet containing ALA+DHA exhibited only minor changes in brain fatty acid composition. These observations demonstrate that brain DHA content of adult animals is vulnerable to depletion under dietary conditions that supply inadequate (n-3) PUFAs, that this effect is augmented by the physiological demands of pregnancy and lactation, and that maternal diet and parity interact to affect maternal brain PUFA status.
| Introduction |
|---|
|
|
|---|
15% of the fatty acids in brain and is derived from the essential fatty acid
-linolenic acid [ALA, 18:3(n-3)]. Another biologically important LC-PUFA, arachidonic acid [AA, 20:4(n-6)], is synthesized from the essential fatty acid linoleic acid [18:2(n-6)]. Other major species of fatty acids in brain include vaccenic acid [18:1(n-7)], oleic acid [18:1(n-9)], and gadoleic acid [20:1(n-9)] (5). Decreased levels of (n-3) LC-PUFAs, including DHA, are associated with depressive illnesses. Although brain fatty acid composition has not been examined in depression, the disease is associated with low (n-3) LC-PUFA consumption and/or altered content in peripheral tissues. Of note, erythrocyte and adipose DHA contents of depressed patients were decreased compared with controls (68) and were correlated with the severity of symptoms (6,8,9) or attempted suicide (10). The prevalence of depression is inversely related to fish consumption, a major dietary source of (n-3) LC-PUFAs (11,12). Furthermore, dietary supplementation with (n-3) LC-PUFAs appears to improve depressive symptoms in controlled clinical trials (1316). Similar to nonpuerperal depression, several studies associate postpartum depression with decreased DHA levels in plasma or breast milk (17,18) or decreased ratio of DHA to (n-6) DPA in plasma (19), and n-3 LC-PUFA supplements were effective in reducing depressive symptoms in a pilot study (20).
Although the fatty acid composition of various tissues can vary over time depending on the availability of specific fatty acids and/or reproductive status (2125), brain DHA content of nonreproducing adult rats appeared to be unaffected by a lack of dietary (n-3) PUFAs (2,21). Recently, we showed that the DHA content of the maternal brain can be reduced after a single reproductive cycle under dietary conditions with reduced availability of (n-3) PUFAs (26), presumably due to the demands of supplying DHA to the developing fetus. This demonstration of the vulnerability of maternal brain DHA to reproduction-related depletion renders viable the hypothesis that altered brain LC-PUFA content, particularly decreased DHA, affects maternal neurobiology. In humans, this could increase sensitivity to stress, and thus susceptibility to postpartum depression, consistent with the diathesis-stress model (27). Despite the growing body of biological findings in nonpuerperal depression (28,29), the pathogenesis of postpartum depression remains unclear (30). Hormonal changes associated with pregnancy and childbirth appear to contribute (31,32); however, the etiology is complex and probably involves the interaction of environmental factors and genetic predispositions. Diets consumed by Western societies are noted for containing low levels of (n-3) PUFAs, particularly relative to (n-6) PUFAs, which compete for elongation and desaturation into LC-PUFAs (33). Moreover, although women appear to have higher rates of conversion of
-linolenic acid, the essential (n-3) PUFA, into DHA than men, humans are relatively inefficient in synthesizing DHA (
8% conversion), and there is considerable variation among individuals (3436). The low rate of conversion and high individual variability suggest the possible value of preformed DHA in the diet. It is recommended that pregnant and lactating women consume at least 300 mg DHA/d although average consumption is <100 mg (37,38). Accordingly, depletion of brain DHA, as a result of diet or metabolic capacity, identifies a potential risk factor for postpartum depression. This risk factor may be of particular importance for multiparous women, who are reported to have greater decreases in plasma DHA levels than primiparous women (23,39) and who appear to be at increased risk for postpartum depression (40,41).
In view of the potential importance of brain fatty acid composition for maternal health and the likelihood that women will consume suboptimal levels of (n-3) PUFAs, particularly LC-PUFAs, this study sought to further examine the effects of reproductive activity on the phospholipid fatty acid composition of the maternal brain after sequential reproductive cycles under dietary conditions varying in (n-3) PUFA content.
| Materials and Methods |
|---|
|
|
|---|
Rats were housed in a temperature- and humidity-controlled animal facility with a 12-h dark:light cycle (on at 0600) and consumed food and water ad libitum. Female, Long-Evans rats (7078 d old; Harlan) were obtained at least 5 d before the commencement of any treatments and were handled regularly.
Experimental diets.
The control diet (ALA) was prepared by adding 7% by weight of pure soybean oil (without partial hydrogenation) as a source of
-linolenic acid to a purified baseline diet (Harlan Teklad Basal Diet TD00235). The ALA diet was identical to Harlan Teklad AIN 93G, which meets all current nutrient standards for rat pregnancy and growth (42). The ALA+DHA diet contained both
-linolenic acid and preformed DHA and was formulated with DHASCO (42.57% DHA by weight; Martek Biosciences) substituted on an equal weight basis for soybean oil such that DHA accounted for 0.7% of the total fat in the diet by weight. The low-ALA diet was formulated with sunflower oil (7% by weight), which contains negligible
-linolenic acid compared with soybean oil. The nutritional composition of the experimental diets is presented in Table 1. The fatty acid compositions of all diets are presented in Table 2.
|
|
At the time of weaning of the last litter, or treatment for the commensurate duration for virgins, rats were killed by decapitation and the brains rapidly removed, frozen on dry ice, and stored at 70°C until used for analysis of fatty acids. Fatty acid composition was determined in one hemisphere of each brain by TLC and GC as previously described (43) and expressed as area percentage.
Data analysis. Results are presented as the mean ± SEM. Data were analyzed for statistically significant main effects by 3-way ANOVA with factors of diet, number of cycles/duration of treatment, and reproductive status. ANOVA and Tukey's test were then used to determine the effects of number of cycles/duration of treatment within each diet group and between virgins and parous dams. Differences were considered significant at P < 0.05. After initial analysis indicating no effect of duration of treatment of the ALA diet in virgin females, data for these rats were pooled across the 4 time points and used as a single "virgin control" group for all subsequent analyses.
| Results |
|---|
|
|
|---|
Adult, virgin, female rats (n = 4/time point) were fed the ALA diet for 6, 13, 20, or 27 wk. Brain phospholipid composition was similar to that previously reported, with palmitic (16:0), stearic (18:0), oleic [18:1(n-9)], and DHA [22:6(n-3)] representing the predominant fatty acid species (44) (Fig. 1). No main effect of duration of treatment on brain fatty acid composition, or interaction of duration of treatment and fatty acid, was detected by 2-way ANOVA (data not shown).
|
|
|
In virgin rats fed the ALA+DHA diet, brain DHA did not differ from that of virgin controls at any time point (Fig. 4). However, (n-6) DPA gradually decreased with duration of treatment, reaching 50% of that of virgin controls at the time equivalent to 3 reproductive cycles (20 wk) (P < 0.05). Accordingly, the DHA:(n-6) DPA ratio gradually increased, reaching a maximum of 197% of that of virgin controls at the time equivalent to 3 reproductive cycles (P < 0.05) (Fig. 2). Other (n-3) fatty acids also decreased to 73% of that of virgin controls after the time equivalent to 1 cycle (6 wk) (P < 0.05), but did not decrease further with additional duration of treatment. Transient decreases in 18:1(n-7) and 20:1(n-9) also occurred over the course of treatment. Levels of saturated fatty acids, other MUFAs, 20:4(n-6), 22:4(n-6), and other (n-6)s did not differ from those of virgin controls at any time point (data not shown).
|
| Discussion |
|---|
|
|
|---|
The present findings demonstrate that brain phospholipid fatty acid composition in both nonreproducing and reproducing female rats can be modulated by a diet low in
-linolenic acid even when the diet preceding this experimental manipulation should have resulted in adequate (n-3) PUFA stores. Although some changes in other fatty acids occurred [e.g., 18:1(n-7), 20:1(n-9)], these alterations were either transitory, small in magnitude, or both. The major effects of the diet treatments in parous and virgin female rats were on DHA with a compensatory alteration in (n-6) DPA, a product derived from linoleic acid. Accordingly, the ensuing discussion will focus on the effects on DHA and (n-6) DPA.
The
-linolenic acidcontaining control diet is identical to AIN 93G, a diet that meets all current nutrient standards for reproducing and developing rats (42). However, this diet has not been investigated with regard to adequacy for maternal brain fatty acid status. Because there were no alterations in brain DHA or (n-6) DPA content in female rats fed the
-linolenic acidcontaining diet undergoing as many as 4 sequential reproductive cycles, nor was there any alteration in the ratio of DHA to (n-6) DPA, the data suggest that the
-linolenic acid in this diet is adequate for reproducing female rats. This observation also indicates that the metabolic capacity and/or the tissue DHA stores of the dam are sufficient to maintain maternal brain DHA content after multiple sequential reproductive cycles without the need for preformed DHA in the diet.
In this study, the inclusion of preformed DHA in the diet containing
-linolenic acid and DHA (ALA+DHA) did not increase brain DHA content in the virgin females, even after 27 wk of treatment. However, brain (n-6) DPA content was reduced after 20 wk of treatment, resulting in an increase in the ratio of DHA to (n-6) DPA, suggesting substitution of DHA for (n-6) DPA in cell membranes (45). Other studies showed that the brain DHA content of adult rats can be increased after treatment with diets containing DHA (4648). The small effect on brain LC-PUFA composition in this study is most likely due to the use of a lower concentration of DHA in the diet, and perhaps also differences in strain and sex. A similar lack of effect of feeding preformed DHA on brain DHA content occurred in reproducing females. However, no gradual decrease in brain (n-6) DPA content occurred, suggesting that what little substitution of DHA for (n-6) DPA that occurred in virgin females did not take place under the demands of pregnancy and lactation.
In contrast to previous reports indicating that brain DHA content of nonreproducing adult rats appeared to be unaffected by a lack of dietary of (n-3) PUFAs (2,21), our findings demonstrate that brain DHA is vulnerable to depletion when rats are fed a diet containing inadequate (n-3) PUFAs for a sufficient period of time. Differences between the present results and previous studies may reflect strain and/or sex differences. However, the formulation of the diets is likely not a factor because the sunflower oil used to prepare the low-ALA diet in this study does contain somewhat higher trace levels of
-linolenic acid than those found in the peanut, safflower, and other oils used in other studies.
In agreement with our previous study (26), brain DHA content was significantly decreased after a single reproductive cycle with consumption of the low
-linolenic acid diet, accompanied by an increase in (n-6) DPA. This observation concurs with previous reports of declines in plasma DHA levels during pregnancy in women (22,25,49) and suggests that reproduction-related depletion of brain DHA may also occur in humans. Interestingly, brain DHA content was not further decreased after subsequent reproductive cycles. This suggests that maternal brain DHA may be resistant to depletion once some minimum level has been reached, at least under the specific conditions of the low
-linolenic acid diet employed here. However, although no further decrease in brain DHA occurred after the first reproductive cycle, (n-6) DPA content continued to increase, reaching maximal levels after 2 cycles, suggesting that the effects of diet and reproductive activity on brain fatty acid composition were not maximal until 2 cycles had been completed. Again, these findings are similar to observations on plasma or erythrocyte DHA levels in humans, indicating greater depletion in multiparous than in null- or primiparous women (23,24,39), but no significant correlation of DHA level with parity (24). The mechanism underlying this apparent basement effect for maternal brain DHA must be determined in future studies but could involve mobilization of peripheral stores and/or increased synthetic capacity, which is stimulated by estrogen (50) and appears to increase during pregnancy (5153). These mechanisms could be further augmented after multiple reproductive cycles.
The specific contributory role of brain fatty acid composition in depressive illnesses remains to be determined. However, LC-PUFAs influence neuronal function in several ways. Within the membranes of neuronal cells, phospholipids form the surrounding microenvironment, and thus influence the conformation and function of receptors, ion channels, and other membrane-bound proteins (2). A number of LC-PUFAs, most notably arachidonic acid, serve as precursors for intracellular signaling molecules such as prostaglandins. Recently, DHA was shown to be the precursor of the neurotrophic factor neuroprotectin D1 (54). In addition, LC-PUFAs can activate transcription factors and thus modulate gene expression (3). Accordingly, any alteration in brain LC-PUFA composition resulting from the interaction of diet and reproductive activity would likely alter maternal neurobiology. The neurobiological effects of altered LC-PUFA in the parous organism, as well as in virgin females fed an
-linolenic-deficient diet long-term, must be determined in future studies. However, alterations in serotonergic function, which is of particular relevance in depression (28,29), are associated with decreased brain DHA. Of note, low plasma DHA levels resulting from alcoholism are correlated with increased cerebrospinal fluid concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (55). Altered serotonergic function was also found in several animal models of decreased brain DHA content. For example, rats with decreased brain DHA content from conception exhibit altered serotonergic neurotransmission and increased density of 5-HT2A receptors (56,57), whereas diets that increased cortical DHA content increased serotonin levels in piglets (58). Other neurotransmitter systems that may play a role in depression, such as dopamine (59), are also affected in rats with low brain DHA content throughout development (60). Consistent with these neurochemical alterations, rats fed an (n-3) PUFAdeficient diet at weaning exhibited increased immobility in the Porsolt forced swim test, an animal model of depression, at adulthood (61).
In conclusion, the present findings indicate that brain DHA content of adult, female rats is vulnerable to depletion when they consume a diet supplying inadequate (n-3) PUFAs. Depletion of brain DHA, and the reciprocal incorporation into (n-6) DPA, is increased by the physiological demands of pregnancy and lactation, with a basement effect occurring after 2 sequential reproductive cycles. Although brain DHA content was maintained in reproducing female rats fed a diet containing
-linolenic acid, but no DHA, the relatively inefficient synthesis of DHA in humans (36) opens the possibility that parous women could be vulnerable to depletion of brain DHA content without the inclusion of preformed DHA in the diet. Furthermore, these observations provide additional support for the hypothesis that reproduction-related depletion of brain DHA content could produce alterations in maternal neurobiology that might increase vulnerability to postpartum mental illness in women and suggest that appropriate (n-3) PUFA content and composition of the diet may be important for maternal health as well as optimal development of the offspring.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Previously published in abstract form (Levant B, Ozias MK, Carlson SE. Maternal parity influences the effects of an
-linolenic acid-deficient diet on maternal and offspring brain docosahexaenoic acid content. International Society for the Study of Fatty Acids and Lipids, Cairns, Australia, July 2328, 2006. ![]()
7 Abbreviations used: ALA,
-linolenic acid; DHA, docosahexaenoic acid; (n-6) DPA, docosapentaenoic acid; FAME, fatty acid methyl ester; LC-PUFA, long-chain polyunsaturated fatty acid; MUFA, monounsaturated fatty acid; P#, postnatal day. ![]()
Manuscript received 1 May 2006. Initial review completed 14 May 2006. Revision accepted 31 May 2006.
| LITERATURE CITED |
|---|
|
|
|---|
1. Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res. 1968;9:5709.[Abstract]
2. Salem N Jr, Litman B, Kim H-Y, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36:94560.[Medline]
3. Uauy R, Mena P, Rojas C. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc. 2000;59:315.[Medline]
4. Horrocks LA, Farooqui AA. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids. 2004;70:36172.[Medline]
5. Sinclair AJ. Long chain polyunsaturated fatty acids in the mammalian brain. Proc Nutr Soc. 1975;34:28791.[Medline]
6. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48:14955.[Medline]
7. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998;43:3159.[Medline]
8. Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A. Depression and adipose polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Prostaglandins Leukot Essent Fatty Acids. 2004;70:495501.[Medline]
9. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85:27591.[Medline]
10. Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, Kang W, Watanabe S, Terasawa K, Hamazaki T. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry. 2004;56:4906.[Medline]
11. Hibbeln J. Fish consumption and major depression. Lancet. 1998;351:1213.[Medline]
12. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H. Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry. 2001;58:5123.
13. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13:26771.[Medline]
14. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar disorder. Am J Psychiatry. 2002;159:4779.
15. Peet M, Horrobin D. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59:9139.
16. Puri BK, Counsell SJ, Richardson AJ, Horrobin DF. Eicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry. 2002;59:912.
17. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord. 2002;69:1529.[Medline]
18. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci. 2003;73:31817.[Medline]
19. Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids. 2003;69:23743.[Medline]
20. Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychatr. Scand. 2006;113:315.[Medline]
21. Bourre JM, Dumont OS, Piciotti MJ, Pascal GA, Durand GA. Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes. Biochim Biophys Acta. 1992;1124:11922.[Medline]
22. Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr. 1995;74:5568.[Medline]
23. Al MD, van Houwelingen AC, Hornstra G. Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur J Clin Nutr. 1997;51:54853.[Medline]
24. van den Ham EC, van Houwelingen AC, Hornstra G. Evaluation of the relation between n-3 and n-6 fatty acid status and parity in nonpregnant women from the Netherlands. Am J Clin Nutr. 2001;73:6227.
25. Holman RT, Johnson SB, Ogburn PL. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A. 1991;88:48359.
26. Levant B, Radel JD, Carlson SE. Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in n-3 polyunsaturated fatty acids. Biol Psychiatry. In press 2006.
27. Monroe SM, Simons AD. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol Bull. 1991;110:40625.[Medline]
28. Duman RS. The neurochemistry of mood disorders. In: Charney DS, Nestler EJ, Bunney BS, editors. Neurobiology of Mental Illness. New York: Oxford University Press; 1999. p. 33347.
29. Garlow SJ, Musselman DL, Nemeroff CB. The neurochemistry of mood disorders: clinical studies. In: Charney DS, Nestler EJ, Bunney BG, editors. Neurobiology of Mental Illness. New York: Oxford University Press; 1999. p. 34864.
30. Stowe ZN, Nemeroff CB. Women at risk for postpartum-onset major depression. Am J Obstet Gynecol. 1995;173:63945.[Medline]
31. Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry. 2002;63: Suppl 7:915.[Medline]
32. McCoy SJ, Beal JM, Watson GH. Endocrine factors and postpartum depression. A selected review. J Reprod Med. 2003;48:4028.[Medline]
33. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:36579.[Medline]
34. Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002;88:41120.[Medline]
35. Burdge GC, Dunn RL, Wootton SA, Jackson AA. Effect of reduced dietary protein intake on hepatic and plasma essential fatty acid concentrations in the adult female rat: effect of pregnancy and consequences for accumulation of arachidonic and docosahexaenoic acids in fetal liver and brain. Br J Nutr. 2002;88:37987.[Medline]
36. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res. 1998;68:15973.[Medline]
37. Simopoulos AP, Leaf A, Salem N Jr. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr. 1999;18:4879.
38. Denomme J, Stark KD, Holub BJ. Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J Nutr. 2005;135:20611.
39. Hornstra G, Al MD, van Houwelingen AC, Foreman-van Drongelen MMHP. Essential fatty acids in pregnancy and early human development. Eur J Obstet Gynecol Reprod Biol. 1995;61:5762.[Medline]
40. Berle JO, Aarre TF, Mykletun A, Dahl AA, Holsten F. Screening for postnatal depression. Validation of the Norwegian version of the Edinburgh Postnatal Depression Scale, and assessment of risk factors for postnatal depression. J Affect Disord. 2003;76:1516.[Medline]
41. Gurel S, Gurel H. The evaluation of determinants of early postpartum low mood: the importance of parity and inter-pregnancy interval. Eur J Obstet Gynecol Reprod Biol. 2000;91:214.[Medline]
42. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:193951.
43. Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res. 2004;152:4957.[Medline]
44. Levant B, Crane JF, Carlson SE. Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:72832.[Medline]
45. Galli C, Trzeciak HI, Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids. Biochim Biophys Acta. 1971;248:44954.
46. Barcelo-Coblijn G, Hogyes E, Kitajka K, Puskas LG, Zvara A, Hackler L Jr, Nyakas C, Penke Z, Farkas T. Modification by docosahexaenoic acid of age-induce alteration in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A. 2003;100:113216.
47. Clements KM, Girard TA, Xing HC, Wainwright PE. Spontaneously hypertensive and Wistar Kyoto rats differ in delayed matching-to-place performance and response to dietary long-chain polyunsaturated fatty acids. Dev Psychobiol. 2003;43:5769.[Medline]
48. Favreliere S, Perault MC, Huguet F, De Javel D, Bertrand N, Piriou A, Durand G. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging. 2003;24:23343.[Medline]
49. Otto SJ, Houwelingen AC, Antal M, Manninen A, Godfrey K, Lopez-Jaramillo P, Hornstra G. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr. 1997;51:23242.[Medline]
50. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr. 2004;80:116774.
51. Burdge GC, Postle AD. Hepatic phospholipid molecular species in the guinea pig. Adaptations to pregnancy. Lipids. 1994;29:25964.[Medline]
52. Otto SJ, van Houwelingen AC, Badart Smook A, Hornstra G. Changes in the maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet. Am J Clin Nutr. 2001;73:3027.
53. Burdge GC, Sherman RC, Ali Z, Wootton SA, Jackson AA. Docosahexaenoic acid is selectively enriched in plasma phospholipids during pregnancy in Trinidadian womenresults of a pilot study. Reprod Nutr Dev. 2006;46:637.[Medline]
54. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005;15:15966.[Medline]
55. Hibbeln JR, Umhau JC, Linnoila M, George DT, Ragan PW, Shoaf SE, Vaughan MR, Rawlings R, Salem N Jr. A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol Psychiatry. 1998;44:2439.[Medline]
56. Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard JC, Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res. 1997;38:6809.[Abstract]
57. Delion S, Chalon S, Herault J, Guilloteau D, Bresnard JC, Durand G. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats. J Nutr. 1994;124:246675.
58. de la Presa Owens S, Innis SM. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J Nutr. 1999;129:208893.
59. Brown RG, Gershon S. Dopamine and depression. J Neural Transm Gen Sect. 1993;91:75109.[Medline]
60. Chalon S, Vancassel S, Zimmer L, Guilloteau D, Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids. 2001;36:93744.[Medline]
61. DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res. 2006;47:17280.
This article has been cited by other articles:
![]() |
B. Levant, M. K. Ozias, and S. E. Carlson Diet (n-3) Polyunsaturated Fatty Acid Content and Parity Affect Liver and Erythrocyte Phospholipid Fatty Acid Composition in Female Rats J. Nutr., November 1, 2007; 137(11): 2425 - 2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Ozias, S. E. Carlson, and B. Levant Maternal Parity and Diet (n-3) Polyunsaturated Fatty Acid Concentration Influence Accretion of Brain Phospholipid Docosahexaenoic Acid in Developing Rats J. Nutr., January 1, 2007; 137(1): 125 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Levant, M. K. Ozias, and S. E. Carlson Specific Brain Regions of Female Rats Are Differentially Depleted of Docosahexaenoic Acid by Reproductive Activity and an (n-3) Fatty Acid-Deficient Diet J. Nutr., January 1, 2007; 137(1): 130 - 134. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||